A Mission for Michael has released a guide on quetiapine, covering its uses as an off-label anxiety medication.
-- A Mission for Michael has published a guide on quetiapine, a medication that is primarily prescribed for psychiatric disorders but can be used off-label to reduce anxiety symptoms. The resource covers benefits, side effects, and contraindications to help readers make an informed decision about whether the medication is suitable for them.
For more information, please visit https://amfmtreatment.com/quetiapine-seroquel/
Quetiapine is an atypical psychotropic medication belonging to a class of drugs known as dibenzothiazepine derivatives. Sold under the brand name Seroquel, quetiapine is mainly used to treat schizophrenia, bipolar disorder, and other psychiatric disorders that cause disruptions in emotional responses, thought processing, and social interactions, or otherwise interfere with daily functioning. Scientists believe that the drug works by restoring the balance of neurotransmitters in the brain while blocking dopamine receptors, often resulting in a reduction in psychotic symptoms and improvements in concentration, moods, and energy levels.
While the drug is not FDA-approved for other uses, doctors may prescribe it off-label for generalized anxiety disorders if patients are unresponsive to first-line anxiety treatments. One literature review in Drug Design, Development and Therapy found that the medication was effective at alleviating anxiety symptoms in adults; A Mission for Michael’s guide adds that it is typically well-tolerated by patients and doesn’t require weekly or monthly laboratory work, unlike other types of psychotropic drugs.
However, the resource says that quetiapine use can still result in side effects. Acute symptoms include vomiting, congestion, headaches, gastrointestinal issues, and dry mouth, but these typically resolve as the body adjusts to dosages. Over the long term, quetiapine can cause irritability, osteoporosis, high blood sugar or cholesterol, weight gain, and tardive dyskinesia, a neurological syndrome that involves involuntary movements in the face, body, and limbs.
A Mission for Michael also notes that individuals may experience uncomfortable withdrawal symptoms if quetiapine is stopped abruptly. Consequently, patients who want to discontinue the medication are advised to do so slowly and with guidance from a healthcare professional.
Quetiapine cannot be mixed with Parkinson’s disease medications and antiarrhythmic drugs, and it may interact with erythromycin, fluvoxamine, carbamazepine, and rifampin. Additionally, older adults with dementia must avoid the medication entirely, as it may increase the risk of death.
More information is available at https://amfmtreatment.com/
Contact Info:
Name: Nathan Di Tomaso
Email: Send Email
Organization: A Mission for Michael (AMFM)
Address: 30310 Rancho Viejo Rd. , San Juan Capistrano, California 92675, United States
Website: https://amfmtreatment.com/
Source: PressCable
Release ID: 89194171
If there are any errors, inconsistencies, or queries arising from the content contained within this press release that require attention or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our reliable team will be available to promptly respond within 8 hours, taking proactive measures to rectify any identified issues or providing guidance on the removal process. Ensuring accurate and dependable information is our top priority.
